Ponatinib 15/30 mg tablets are a key treatment for chronic myeloid leukemia (CML), especially effective for patients with resistant mutations. By targeting BCR-ABL gene mutations, offers improved remission possibilities. Ponatinib 15 / 30 mg in India, is vital for advanced CML cases. Patients can access this innovative treatment through Impomed Healthcare.